PMID- 32205313 OWN - NLM STAT- MEDLINE DCOM- 20210628 LR - 20210628 IS - 1468-201X (Electronic) IS - 1355-6037 (Linking) VI - 106 IP - 18 DP - 2020 Sep TI - Cardiac catheter intervention complexity and safety outcomes in adult congenital heart disease. PG - 1432-1437 LID - 10.1136/heartjnl-2019-316148 [doi] AB - OBJECTIVE: To describe the intervention spectrum, complexity, and safety outcomes of catheter-based interventions in a contemporary adult congenital heart disease (ACHD) tertiary cohort. METHODS: All patients over 16 years who underwent a catheter-based intervention for ACHD in our centre between 2000 and 2016 were included. Baseline demographics, clinical characteristics, indications for and complexity of intervention, procedural complications and early and mid-term mortality were analysed. RESULTS: Overall, 1644 catheter-based interventions were performed. Intervention complexity ranged from simple (67.5%) to intermediate (26.4%) and to high (6.1%). Commonly performed procedures were atrial septal defect (33.4%) and patent foramen ovale closure (26.1%) followed by coarctation of the aorta (11.1%) and pulmonary artery interventions (7.0%). Age at index intervention was 40+/-16 years, 758 (46.1%) patients were male, 73.2% in New York Heart Association (NYHA) class I, 20.2% in NYHA class II, whereas 6.6% in NYHA class III/IV. In-hospital mortality was 0.7%. Median postinterventional length of stay was 1 day. Complications occurred in 129 (7.9%) with major adverse events in 21 (1.3%). One-year postintervention survival rates were 98.7% (95% CI 98.2 to 99.2). Over the study period, there was a notable shift in intervention complexity, with a predominance of simple procedures performed in early years and more complex procedures in later years. Furthermore, the case mix during the study broadened (p<0.001) with new catheter-based interventions and a more individualised approach to therapy. CONCLUSION: This study shows an increasing complexity and expanding variability of ACHD catheter-based interventions, associated with low major complications, short hospital stays and low early and mid-term mortality. Ongoing investment in ACHD catheter interventions is warranted. CI - (c) Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. FAU - Brida, Margarita AU - Brida M AUID- ORCID: 0000-0001-8754-8156 AD - Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK margarita.brida@icloud.com. AD - Division of Adult Congenital Heart Disease, Department of Cardiovascular Medicine, University Hospital Centre, Zagreb, Croatia. AD - National Heart and Lung Institute, Imperial College London, London, UK. FAU - Diller, Gerhard Paul AU - Diller GP AUID- ORCID: 0000-0003-3050-5248 AD - Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK. AD - Adult Congenital and Valvular Heart Disease Center, Department of Cardiology and Angiology, University Hospital Muenster, Muenster, Germany. FAU - Nashat, Heba AU - Nashat H AD - Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK. FAU - Barracano, Rosaria AU - Barracano R AUID- ORCID: 0000-0002-6380-073X AD - Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK. FAU - Kempny, Aleksander AU - Kempny A AD - Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK. AD - National Heart and Lung Institute, Imperial College London, London, UK. FAU - Uebing, Anselm AU - Uebing A AD - Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK. FAU - Rigby, Michael L AU - Rigby ML AD - Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK. FAU - Gatzoulis, Michael A AU - Gatzoulis MA AD - Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK. AD - National Heart and Lung Institute, Imperial College London, London, UK. LA - eng GR - BHF_/British Heart Foundation/United Kingdom GR - DH_/Department of Health/United Kingdom PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20200323 PL - England TA - Heart JT - Heart (British Cardiac Society) JID - 9602087 SB - IM MH - Adolescent MH - Adult MH - *Cardiac Catheterization/adverse effects/mortality MH - Female MH - Heart Defects, Congenital/diagnosis/mortality/physiopathology/*therapy MH - Humans MH - London MH - Male MH - Middle Aged MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Survivors MH - Time Factors MH - Treatment Outcome MH - Young Adult OTO - NOTNLM OT - congenital heart disease OT - interventional cardiology and endovascular procedures COIS- Competing interests: None declared. EDAT- 2020/03/25 06:00 MHDA- 2021/06/29 06:00 CRDT- 2020/03/25 06:00 PHST- 2019/10/27 00:00 [received] PHST- 2020/01/29 00:00 [revised] PHST- 2020/02/04 00:00 [accepted] PHST- 2020/03/25 06:00 [pubmed] PHST- 2021/06/29 06:00 [medline] PHST- 2020/03/25 06:00 [entrez] AID - heartjnl-2019-316148 [pii] AID - 10.1136/heartjnl-2019-316148 [doi] PST - ppublish SO - Heart. 2020 Sep;106(18):1432-1437. doi: 10.1136/heartjnl-2019-316148. Epub 2020 Mar 23.